The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis

Published:2016-04-13 Issue:4 Volume:11 Page:e0152500
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mao Yan,Qu Qing,Chen Xiaosong,Huang Ou,Wu Jiayi,Shen Kunwei

Funder

Doctor Innovation funding of Shanghai Jiao Tong University School of Medicine

National Natural funding of China

Shanghai Municipal Science and Technology Commission funding

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference51 articles.

1. Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer;F Andre;Clin Cancer Res,2013

2. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02–98;S Loi;J Clin Oncol,2013

3. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer;SM Mahmoud;J Clin Oncol,2011

4. Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas;S Menard;Clin Cancer Res,1997

5. The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer;ZM Mohammed;Br J Cancer,2012

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of clinicopathologic and sonographic features with stromal tumor-infiltrating lymphocytes in triple-negative breast cancer;BMC Cancer;2024-08-12

2. Association of GATA3 expression in triple-positive breast cancer with overall survival and immune cell infiltration;Scientific Reports;2024-08-01

3. A prognostic and predictive computational pathology immune signature for ductal carcinoma in situ: retrospective results from a cohort within the UK/ANZ DCIS trial;The Lancet Digital Health;2024-08

4. Tumor microenvironment and immune response: A gateway to novel therapies in gastrointestinal cancers;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-06

5. Pharmacological Mechanism of Mume Fructus in the Treatment of Triple-Negative Breast Cancer Based on Network Pharmacology;Applied Biochemistry and Biotechnology;2024-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3